Skip to content
Search

Latest Stories

NHS waiting lists test mental health of non-Covid patients

NHS waiting lists test mental health of non-Covid patients

PATIENTS waiting for vital NHS health checks are experiencing mental health issues due to the stress over postponed tests and surgeries, an Asian health campaigner has warned.

Following the coronavirus pandemic and the overwhelming strain on the country’s healthcare resources, the NHS has had to postpone many key assessments tests or patients as it works through the Covid backlog.


In June, the overall waiting list for tests (including MRIs and heart scans) was 1.4 million patients. This was an increase of 28 per cent compared with two years prior, NHS England analysis showed.

Kirit Mistry is the chair of South Asian Health Action and helps to facilitate patient groups – including one for south Asian patients with diabetes and another for kidney disease.

LEAD Tests INSET Kirit Mistry Kirit Mistry

Mistry said he has been supporting some individuals who have had various procedures delayed. He has spoken to kidney disease patients whose transplant surgeries have been postponed.

“It has a big impact on their mental health,” he told Eastern Eye. “There is an uncertainty of not knowing if your condition is spiralling out of control, and that can be very worrying.”

Although Mistry said he understood that procedures have been delayed due to the pandemic’s impact, the NHS needed to communicate with patients about the ongoing situation.

“Better communication would alleviate people’s mental health challenges, by [the NHS] keeping in regular contact and saying, ‘we’re aware your checks have to be done and just bear with us’,” he explained. “That lack of communication doesn’t help people and can leave them anxious or depressed. It certainly has an impact on the wellbeing and mental health (of those patients).”

'The NHS is under resourced'

Rachel Power is the chief executive of Patients Association, a charity aiming to improve patients’ experience of healthcare. She acknowledged the “huge challenge” that the NHS has faced during the ongoing pandemic and said its ability to provide non-Covid-19 care has been “seriously affected”.

“Now the NHS needs more resources – money and staff – and strong leadership to treat and care for the many patients on waiting lists,” she told Eastern Eye.

Echoing Mistry’s view, Power said the NHS needed to understand the impact on

patients who were waiting for tests. “(The NHS needs to) act in response,” Power remarked. “This means clear communication to patients whose treatment is cancelled or postponed, with expectations about what might happen next.

“Extra support to help people remain as well as possible in their own homes should be provided when possible.”

Last Thursday (26), the Health Foundation think-tank cautioned that delays in diabetes diagnosis and treatment could have severe impacts on patients and the NHS.

Data showed there were 26 per cent fewer new cases of type 2 diabetes diagnosed in 2020 compared to 2019 in England. People suffering with diabetes usually have an annual check-up – including an examination of their eyes, kidneys, and feet for signs of complications related to the condition – but many of these were cancelled, delayed, or moved online, leading to reductions in patient monitoring.

For example, the Health Foundation found HbA1c testing (a measure of average blood glucose levels for the last two-to-three months) was 43 per cent lower in 2020 than in 2019. Referrals to diabetes nurses and education programmes were 35 per cent lower.

Mistry, who has type 2 diabetes himself, said he was concerned about the backlog. “We know that during the pandemic, people’s diabetes may have gotten bad because their lifestyle or diet couldn’t be managed properly because of them being at home,” he explained. “The importance of regular blood tests which gives us a three-month variation of how our blood levels are doing is vital.

“It is going to cost the NHS more in the long run and cause complications.”

Responding to Eastern Eye, an NHS spokesperson said treating thousands of patients for Covid-19 had inevitably had an impact on other parts of the health service. However, they noted the NHS was already showing strong signs of recovery in areas including diagnostics, with almost two million tests in June alone.

They said: “The NHS is continuing to urge anyone with health concerns or symptoms to come forward so we can help you. Latest figures show that the average waiting time for a diagnostic test has fallen to less than three weeks, and the number of patients waiting six weeks or more has dropped by more than a third since this time last year."

More For You

Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Naga Munchetty urges women to prioritise their health

Naga Munchetty

Naga Munchetty urges women to prioritise their health

WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.

Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.

Keep ReadingShow less
London temple project for Shree Banke Bihari launched

London temple project for Shree Banke Bihari launched

Mahesh Liloriya

The Shree Kunj Bihari Vrindavan (UK) Temple has officially launched its project to establish a grand home for Shree Banke Bihari in London.

The inaugural event, held in Harrow from 4 pm, featured devotional chants, the Deep Pragtya ceremony, and a presentation outlining the temple’s vision. Speaking at the gathering, Shalini Bhargava described the planned temple as “a spiritual home promoting bhakti, unity and seva for generations to come.”

Keep ReadingShow less
Dickie and Watt

Dickie and Watt launched BrewDog at the age of 24

Getty Images

BrewDog co-founder Martin Dickie leaves after 17 years as James Watt steps back

Highlights:

  • Martin Dickie has announced his departure from BrewDog and the alcohol industry.
  • He co-founded the Ellon-based brewer with James Watt in 2007.
  • Dickie cited family time and personal reasons for his exit.
  • His departure follows recent bar closures as part of a company restructuring.
  • BrewDog confirmed no further leadership changes will follow.

BrewDog co-founder Martin Dickie has announced he is leaving the Scottish brewer and the wider alcohol industry for “personal reasons.” Dickie, who founded the Ellon-based business with James Watt in 2007, said he wanted to spend more time with his family after more than two decades in brewing and distilling.

Early beginnings

Dickie and Watt launched BrewDog at the age of 24, starting from a garage in Fraserburgh and selling hand-filled bottles from a van at local markets. The company grew rapidly to become one of the UK’s best-known craft brewers.

Keep ReadingShow less